Abstract |
The objective of this study was to evaluate the potential of dynamic contrast-enhanced MRI for quantitative characterization of tumor microvessels and to assess the microvascular changes in response to isolated limb perfusion with TNF-alpha and melphalan. Dynamic contrast-enhanced MRI was performed in an experimental cancer model, using a macromolecular contrast medium, albumin-(Gd-DTPA)45. Small fragments of BN 175, a soft-tissue sarcoma, were implanted in 11 brown Norway (BN) rats. Animals were assigned randomly to a control ( Haemaccel) or drug-treated group ( TNF-alpha/ melphalan). MRI was performed at baseline and 24 h after ILP. The transendothelial permeability (K(PS)) and the fractional plasma volume (fPV) were estimated from the kinetic analysis of MR data using a two-compartment bi-directional model. K(PS) and fPV decreased significantly in the drug-treated group compared to baseline (p<0.05). In addition, K(PS) post therapy was significantly lower (p<0.05) in the drug-treated group than in the control group. There was no significant difference in fPV between the drug-treated and the control group after therapy. Tumor microvascular changes in response to isolated limb perfusion can be determined after 24 h by dynamic contrast-enhanced MRI. The data obtained in this experimental model suggest possible applications in the clinical setting, using the appropriate MR contrast agents.
|
Authors | A Preda, P A Wielopolski, T L M Ten Hagen, M van Vliet, J F Veenland, G Ambagtsheer, S T van Tiel, M W Vogel, A M M Eggermont, G P Krestin, C F van Dijke |
Journal | Magma (New York, N.Y.)
(MAGMA)
Vol. 17
Issue 3-6
Pg. 296-302
(Dec 2004)
ISSN: 0968-5243 [Print] Germany |
PMID | 15480945
(Publication Type: Evaluation Study, Journal Article)
|
Chemical References |
- Albumins
- Contrast Media
- Macromolecular Substances
- Tumor Necrosis Factor-alpha
- albumin-(gadolinium-DTPA)
- Gadolinium DTPA
- Melphalan
|
Topics |
- Albumins
- Animals
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage)
- Chemotherapy, Cancer, Regional Perfusion
(methods)
- Contrast Media
- Extremities
(blood supply)
- Gadolinium DTPA
- Image Enhancement
(methods)
- Macromolecular Substances
- Magnetic Resonance Imaging
(methods)
- Male
- Melphalan
(administration & dosage)
- Prognosis
- Rats
- Rats, Inbred BN
- Sarcoma, Experimental
(diagnosis, drug therapy)
- Treatment Outcome
- Tumor Necrosis Factor-alpha
(administration & dosage)
|